Snakebite envenomation

Maria Menaka A 1, Dhariniya S2, Ruby Ravichandran3

1Senior Staff Nurse, PICU, Maa Kauvery Hospital, Tamil Nadu

2Nursing Educator, Maa Kauvery Hospital, Tamil Nadu

3Senior Deputy Nursing Superintendent, Maa Kauvery Hospital, Tamil Nadu

*Correspondence

Abstract

Snakebite envenomation is a major public health concern in tropical countries, particularly in India, where neurotoxic snakebites can cause life-threatening neuromuscular paralysis and respiratory failure. Common krait (Bungarus caeruleus) envenomation is an important cause of neuroparalytic syndrome, often presenting during the early morning hours. This case report describes a 2-year-and-6-month-old male child who presented with sudden-onset abdominal pain, excessive salivation, reduced activity, altered consciousness, ptosis and progressive neuromuscular weakness. Although there was no definite history of snakebite or visible bite marks, the clinical presentation raised suspicion of neurotoxic envenomation, particularly common krait poisoning. The child developed severe respiratory compromise with hypoxemia and respiratory acidosis, requiring endotracheal intubation and mechanical ventilation. He received 20 vials of anti-snake venom (ASV), along with supportive management and intensive monitoring in the Paediatric Intensive Care Unit (PICU). Gradual neurological and respiratory recovery was observed, allowing successful extubation on the third day and subsequent weaning to room air. He was shifted to the paediatric ward and discharged in a clinically stable condition. This case highlights the importance of early recognition, timely administration of antivenom, respiratory support and comprehensive paediatric critical care management in neurotoxic snake envenomation.

Key words: Snakebite envenomation; Anti-snake venom (ASV)

Introduction

Snakebite envenomation is a potentially life-threatening medical emergency and remains an important public health problem in India. The major medically significant venomous snakes include the common krait, Indian cobra, Russell’s viper and saw-scaled viper. Among these, the common krait (Bungarus caeruleus) is particularly associated with neurotoxic manifestations that can progress rapidly to respiratory muscle paralysis. Krait bites frequently occur at night or during the early morning hours, sometimes while individuals are sleeping. The bite may be painless and local swelling or visible bite marks may be absent. Consequently, patients may not recognize that snakebite has occurred. Early symptoms can include abdominal pain, vomiting, ptosis, ophthalmoplegia, difficulty swallowing, excessive salivation and generalized muscle weakness. Severe envenomation may result in respiratory paralysis, requiring mechanical ventilation. According to the World Health Organization (WHO), timely administration of appropriate antivenom and adequate supportive respiratory care are essential components of snakebite management. The clinical outcome depends on early identification of neurotoxicity, appropriate treatment and continuous monitoring. This case demonstrates the successful management of probable krait-related neuroparalytic syndrome in a young child through multidisciplinary paediatric critical care.

A 2-year-and-6-month-old male child was brought to the hospital with a history of sudden-onset abdominal pain at approximately 2:00 AM, followed by excessive drooling of saliva from around 4:00 AM. The parents subsequently noticed decreased activity, reduced responsiveness to verbal commands, generalized floppiness, altered breathing pattern and drooping of the eyelids. There was no history of loose stools, constipation or abdominal distension. The child was initially taken to a nearby hospital, where brief seizure-like activity characterized by clonic movements lasting approximately 5-10 seconds was observed. He received a loading dose of intravenous levetiracetam (Levipil), intravenous midazolam and a stat dose of intravenous dexamethasone. Oxygen support was initiated through a face mask, following which he was referred to the tertiary care hospital for further evaluation and management. There was no reported history of fever, haematuria, bleeding manifestations, known snakebite or drug ingestion. The absence of a definite bite history did not exclude neurotoxic envenomation because krait bites may occur unnoticed, particularly during sleep. The child’s past medical history was insignificant. He was born with a birth weight of 2.4 kg, through lower-segment caesarean section. There was no history of neonatal intensive care admission. His developmental milestones were appropriate for age, and immunizations were completed up to the age. The parents were non-consanguineous.

Clinical findings

On arrival at the emergency department, the child appeared critically ill with reduced consciousness and respiratory compromise. His Glasgow Coma Scale (GCS) was documented as E1V1M4 in the emergency assessment, with a subsequent documented assessment of E1V1M3. His pupils were unequal, measuring approximately 2.5 mm on the right and 2 mm on the left, but both were reactive to light. Neurological examination revealed generalized hypotonia involving all four limbs, with muscle power markedly reduced, absent deep tendon reflexes and mute plantar responses. There were no signs of meningeal irritation. The child’s temperature was 98°F, heart rate was 130 beats/minute, respiratory rate was 16 breaths/minute and blood pressure was 110/70 mmHg. Oxygen saturation was critically low at 68% despite oxygen support. Random blood glucose was elevated to 297 mg/dL. Peripheral pulse volume was good. Respiratory examination revealed equal bilateral air entry with bradypnea and stridor. Cardiovascular examination showed normal first and second heart sounds without murmurs. Abdominal examination revealed a soft abdomen with audible bowel sounds and no organomegaly. Head-to-toe examination did not reveal any visible snakebite marks. Anthropometric measurements showed a weight of 12 kg, height of 90 cm and head circumference of 48 cm. The clinical presentation of ptosis, excessive salivation, generalized flaccid weakness, absent reflexes and respiratory depression strongly suggested a neuroparalytic process.

Investigations and results

Initial laboratory investigations revealed lymphocytic leucocytosis and mild thrombocytosis. C-reactive protein (CRP) was negative. Serum electrolytes, renal function tests, liver function tests and coagulation profile were within normal limits. Random blood glucose was elevated to 297 mg/dl. Arterial blood gas analysis revealed severe respiratory acidosis, indicating inadequate ventilation and carbon dioxide retention secondary to respiratory muscle weakness. This finding, together with severe hypoxemia, necessitated immediate airway protection and ventilatory support. Endotracheal aspirate was sent for culture and sensitivity in view of respiratory support and was reported as sterile. Contrast-enhanced Magnetic Resonance Imaging (MRI) of the brain was normal, making a structural intracranial abnormality less likely as the cause of the neurological manifestations. The combination of clinical neuroparalysis, respiratory failure, absence of significant inflammatory markers and normal neuroimaging supported the clinical suspicion of neurotoxic snake envenomation.

Diagnosis

The final clinical diagnosis was early morning neuroparalytic syndrome secondary to probable krait envenomation. The diagnosis was based primarily on the characteristic clinical presentation, including early morning abdominal pain, excessive salivation, ptosis, altered sensorium, generalized hypotonia, absent deep tendon reflexes and progressive respiratory muscle paralysis. Although no definite history of snakebite or visible bite marks was available, the clinical features were highly suggestive of neurotoxic envenomation.

Management

The child was managed as a paediatric emergency with immediate attention to airway, breathing and circulation. In view of severe hypoxemia, bradypnoea and respiratory acidosis, endotracheal intubation was performed and invasive mechanical ventilation was initiated. Intravenous fluids and supportive treatment were provided, and the child was shifted to the PICU for continuous neurological and respiratory monitoring. Considering the strong clinical suspicion of neurotoxic snake envenomation, 20 vials of anti-snake venom were administered according to the treatment team’s management plan. Intravenous ceftriaxone was initiated, and maintenance intravenous levetiracetam was continued. Midazolam and fentanyl infusions were administered for sedation and analgesia during mechanical ventilation. Other supportive medications included intravenous fluids, vitamin K, pantoprazole and other prescribed supportive therapies. Nebulization with 3% normal saline and mucolytic therapy were also provided as indicated. Continuous monitoring of oxygen saturation, respiratory parameters, neurological status, haemodynamic stability and urine output was performed. The multidisciplinary PICU team provided ongoing assessments to identify complications and evaluate readiness for ventilator weaning.

Outcome

Following initiation of anti-snake venom and mechanical ventilation, the child’s neurological and respiratory condition gradually improved. Pupillary equality was restored, and neuromuscular weakness showed progressive recovery. The child was continued on invasive mechanical ventilation with regular neurological assessment. On the second day of PICU admission, during the sedation window, the child demonstrated minimal spontaneous eye opening, normal limb movements and good spontaneous respiratory efforts. A Spontaneous Breathing Trial (SBT) was performed, which he tolerated well. His cough and gag reflexes were intact, indicating adequate recovery of airway-protective reflexes. Therefore, he was successfully extubated to High-Flow Nasal Cannula (HFNC) support on the third day of PICU admission. Following extubation, the child continued to have tachypnoea with a paradoxical breathing pattern. Point-of-Care Lung Ultrasound (POCUS) revealed left lower-lobe collapse. Nebulization and chest physiotherapy were initiated, while HFNC support was continued. His respiratory status gradually improved, and oxygen support was successfully discontinued. He was weaned into room air on the following day. The child’s neurological condition also improved significantly. He started recognizing his mother, resumed oral feeding and gradually regained the ability to sit with support. By the fifth day of PICU admission, he was hemodynamically stable, maintaining adequate oxygen saturation on room air without respiratory distress or paradoxical breathing. He tolerated an oral soft diet well and was subsequently shifted to the paediatric ward for further observation and management. During the ward stay, the child remained hemodynamically stable. Nebulization and chest physiotherapy were continued. His hydration, urine output, respiratory status and oral intake were satisfactory. Following significant clinical improvement, he was considered fit for discharge.

Discharge

At the time of discharge, the child was clinically stable, afebrile and adequately hydrated, with satisfactory urine output and stable vital signs. Respiratory and neurological status had improved, and there was no evidence of ongoing respiratory distress. His discharge weight was 11.9 kg. The parents were advised to continue the prescribed medications and follow the recommended dietary instructions. The discharge medications included calcium, magnesium, phosphorus, zinc and vitamin D3 supplementation (CalciMax-P), multivitamin syrup (A to Z), and amoxicillin-clavulanic acid syrup (Augmentin) for the prescribed two-day course and paracetamol syrup (P250) as needed for fever. The parents were instructed to seek immediate medical attention if the child developed excessive drowsiness, persistent cough, cold symptoms, high-grade fever, fast breathing, breathing difficulty, excessive diarrhea, and vomiting or reduced urine output. They were advised to attend the scheduled pediatric follow-up appointment.

Conclusion

Neuroparalytic snake envenomation is a potentially fatal emergency in children because progressive neuromuscular paralysis can rapidly lead to respiratory failure. Common krait envenomation should be considered in children presenting with early morning abdominal pain, ptosis, excessive salivation, altered sensorium and generalized flaccid paralysis, even in the absence of a definite history of snakebite or visible bite marks. This report highlights the importance of early clinical recognition, prompt airway stabilization, timely administration of anti-snake venom and appropriate mechanical ventilation in managing severe neurotoxic envenomation. Successful extubation, gradual neurological recovery and restoration of independent respiratory function emphasize the importance of comprehensive PICU management and multidisciplinary care. Parental education, timely referral, continuous monitoring and appropriate follow-up are essential to ensure complete recovery and prevent complications. Early intervention and adequate supportive management can significantly improve outcomes in children with severe neuroparalytic snakebite envenomation.

References

  1. World Health Organization. (2016). Guidelines for the management of snakebites (2nd ed.). WHO Regional Office for South-East Asia. https://www.who.int/publications/i/item/9789290225300
  2. Pannu, A. K., Chand, D., Bhalla, A., & Dhibar, D. P. (2024). Efficacy of a low dose of antivenom for severe neuroparalysis in Bungarus caeruleus (common krait) envenomation: A pilot study. Toxicology Research, 13(2), tfae023. https://doi.org/10.1093/toxres/tfae023
  3. Ministry of Health and Family Welfare, Government of India. (2024). National action plan for prevention and control of snakebite envenoming (NAP-SE). National Centre for Disease Control.
  4. World Health Organization. (2026). Snakebite envenoming. https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming
Kauvery Hospital